Results 251 to 260 of about 5,851,461 (307)

Anti‐CD20 Discontinuation Versus Continuation in People Aged Over 50 With Non‐Active Multiple Sclerosis

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective To determine whether discontinuing anti‐CD20 therapy in people with relapsing‐onset MS aged over 50 is associated with an increased risk of relapse, inflammatory activity, confirmed disability accrual, and serious infection compared with continuing therapy.
Alexia Moukhine   +40 more
wiley   +1 more source

Data driven selection of consensus docking pipelines for structure based hit identification. [PDF]

open access: yesNPJ Drug Discov
Agha H   +6 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy